From: The impact of vildagliptin on the daily glucose profile and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE—A multicenter randomized controlled trial
Variables
Vildagliptin group (n = 10)
Control group (n = 10)
p Value
Cardiac death, %
0
Myocardial infarction, %
Cerebral infarction, %
Target lesion revascularization, %
10
1.000
Target vessel revascularization, %
20
0.473